Form D · Biotechnology
Peptilogics, Inc.
Pittsburgh, PA · CIK 0001663983
Offering snapshot reported Dec 30, 2020 · SEC filing
- Reported sold
- $35.8M Offering amount: $35.8M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 15, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 30, 2020 | Initial | $35,777,098 | No comparison | 19 | SEC filing |
| Aug 31, 2017 | Initial | $4,000,000 | No comparison | 1 | SEC filing |
| May 11, 2017 | Initial | $753,999 | No comparison | 7 | SEC filing |
| Jan 21, 2016 | Initial | $416,761 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-384820
Source: Form D, filed Dec 30, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jason Camm | Director |
| Stephan Dietrich | Director |
| Hannes Holste | Director |
| Sanjay Kakkar | Director, Executive |
| Catherine Mott | Director |
| Stefan Roever | Director |
| Jonathan Steckbeck | Director, Executive |
| Dietrich Stephan | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3710 Forbes Avenue 2 Nd Floor
Pittsburgh, PA, 15123
Pittsburgh, PA, 15123